 BOSTON, Nov. 25, 2020 GLOBE NEWSWIRE -- Atea Pharmaceuticals, Inc. Nasdaq: AVIR Atea, a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing antiviral therapeutics to improve the lives of patients suffering from life-threatening viral infections, today announced that management will participate in a fireside chat at the Evercore ISI 3rd Annual HealthCONx Conference on Thursday, December 3, 2020 at 12:35 p.m. ET. 